Adjuvant Aumolertinib in Patients with Completely Resected, Stage IA2-IIIA Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations

被引：0

作者：

Zhang, Q. ^{[1
]}

Ke, L. ^{[1
]}

Huang, S. ^{[2
]}

Yang, Y. ^{[1
]}

He, T. ^{[1
]}

Sun, H. ^{[3
]}

Wu, Z. ^{[1
]}

Zhang, X. ^{[4
]}

Lv, W. ^{[1
]}

Hu, J. ^{[1
]}

Ye, J. ^{[1
]}

机构：

[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China

[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China

[3] Zhejiang Univ, Taizhou Hosp, Taizhou, Peoples R China

[4] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

Aumolertinib; Adjuvant; Uncommon EGFR mutations;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP.07E.07

引用

页码：S555 / S556

页数：2

共 50 条

[11] Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
Greco, FA
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09): : 689 - 689
[12] Adjuvant chemotherapy with UFT for completely resected pathologic stage I non-small-cell lung cancer
Paik, H
Kim, D
Hwang, J
Lee, D
LUNG CANCER, 2005, 49 : S358 - S358
[13] Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer
Masafumi Kawamura
Keisuke Eguchi
Yotaro Izumi
Yasushi Yamato
Teruaki Koike
Hirozo Sakaguchi
Enjo Hada
Koichi Kobayashi
Cancer Chemotherapy and Pharmacology, 2007, 60 : 495 - 501
[14] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer - Part 1
Movsas, B
ONCOLOGY-NEW YORK, 2001, 15 (12): : 1549 - 1558
[15] Adjuvant chemotherapy for completely resected non-small-cell lung cancer. Reply
Keller, SM
Johnson, DH
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09): : 690 - 690
[16] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
Le Chevalier, T
Arriagada, R
Le Péchoux, C
Grunenwald, D
Dunant, A
Pignon, JP
Tarayre, M
Abratt, R
Arriagada, R
Bergman, B
Gralla, R
Grunenwald, D
Le Chevalier, T
Orlowski, T
Papadakis, E
Pinel, MIS
Araujo, C
Della Torre, H
de Solchaga, MM
Abdi, E
Blum, R
Ball, D
Basser, R
De Boer, R
Bishop, J
Brigham, B
Davis, S
Fox, D
Richardson, G
Wyld, D
Pirker, R
Humblet, Y
Delaunois, L
Van Meerbeeck, JP
Germonpre, P
Vansteenkiste, J
Nackaerts, K
Pinel, MIS
Vauthier, G
Younes, RN
Arriagada, R
Baeza, R
Carvajal, P
Kleinman, S
Orlandi, L
Castro, C
Godoy, J
Kosatova, K
Gaafar, R
Azarian, R
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04): : 351 - 360
[17] Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives
Pirker, Robert
Filipits, Martin
CLINICAL LUNG CANCER, 2019, 20 (01) : 1 - 6
[18] Aumolertinib after Adjuvant Chemotherapy/Radiotherapy in Stage pIIIA-N2 Non-Small-Cell Lung Cancer with EGFR Mutation
Zhang, Y.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S289 - S289
[19] Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients
Li, Xiao
Zhang, Chao
Sun, Zewen
Yang, Fan
Xiao, Rongxin
Sui, Xizhao
Jiang, Guanchao
Zhong, Wenzhao
Wang, Jun
LUNG CANCER, 2019, 133 : 75 - 82
[20] Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
Yamada, Yutaka
Tamura, Tomohiro
Yamamoto, Yusuke
Ichimura, Hideo
Hayashihara, Kenji
Saito, Takefumi
Yamada, Hideyasu
Endo, Takeo
Nakamura, Ryota
Inage, Yoshihisa
Satoh, Hiroaki
Iguchi, Kesato
Saito, Kazuto
Inagaki, Masaharu
Kikuchi, Norihiro
Kurishima, Koichi
Ishikawa, Hiroichi
Sakai, Mitsuaki
Kamiyama, Koichi
Shiozawa, Toshihiro
Hizawa, Nobuyuki
Sekine, Ikuo
Sato, Yukio
Funayama, Yasunori
Miyazaki, Kunihiko
Kodama, Takahide
Hayashi, Shigen
Nomura, Akihiro
Nakamura, Hiroyuki
Furukawa, Kinya
Yamashita, Takaaki
Okubo, Hatsumi
Suzuki, Hisashi
Kiyoshima, Moriyuki
Kaburagi, Takayuki
ANTICANCER RESEARCH, 2020, 40 (10) : 5757 - 5764

← 1 2 3 4 5 →